• +86-0635-6175299
  • li_ye@inyelchem.com
  • Company Details

 Shandong Haohong Biotechnology Co., Ltd.

HomeNewsSupply of high-quality Macitentan

Supply of high-quality Macitentan

2021-06-02

Shandong Haohong Biotechnology Co., Ltd is mainly focuses on the development of anti-cancer, anti-diabets series of API and its advanced intermediates. The main products include Bicalutamide, enzalutamide, apalutamide, macitentan, cabozantinib, ceritinib, empagliflozin, tofacitinib citrate, and alectinib,etc. In line with the concept of "truth-seeking, innovation and integrity", we had exported our products to the United States, European countries, Japan, India, Bangladesh and other overseas markets. At present, Our company has dozens of advanced intermediates, all of which are commercialized.


Macitentan (trade name Opsumit) is an endothelin receptor antagonist (ERA) approved for the treatment of pulmonary arterial hypertension (PAH). The other two ERAs marketed as of 2014 are bosentan and ambrisentan. Macitentan is a dual ERA, meaning that it acts as an antagonist of two endothelin (ET) receptor subtypes, ETA and ETB. However, macitentan has a 50-fold increased selectivity for the ETA subtype compared to the ETB subtype. The drug received approval from the U.S. Food and Drug Administration (FDA) on October 13, 2013. Macitentan has always been one of the main products promoted by our company.The product purity is at least 99%.Our company always pays attention to product quality and strictly controls quality.

macitentan-1macitentan-2macitentan-3



If you want to know more information about our company and products, please visit our website at http://www.haohongpharma.com. We will offer the best price and the best quality for you.






HomeNewsSupply of high-quality Macitentan

Home

Product

Whatsapp

About Us

Inquiry

We will contact you immediately

Fill in more information so that we can get in touch with you faster

Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.

Send